These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24507885)

  • 1. Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
    Fervaha G; Agid O; Foussias G; Remington G
    J Psychiatr Res; 2014 May; 52():50-6. PubMed ID: 24507885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition.
    Robertson DA; Hargreaves A; Kelleher EB; Morris D; Gill M; Corvin A; Donohoe G
    Schizophr Res; 2013 May; 146(1-3):363-5. PubMed ID: 23422729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia.
    Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG
    Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.
    Lee SH; Sung K; Lee KS; Moon E; Kim CG
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():213-9. PubMed ID: 24161665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report].
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Pankowski D; Denisiuk M; Linke M; Jarema M; Wichniak A
    Psychiatr Pol; 2014; 48(6):1189-200. PubMed ID: 25717488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Hurford IM; Ventura J; Marder SR; Reise SP; Bilder RM
    Schizophr Res; 2018 May; 195():327-333. PubMed ID: 28918221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognition, functional capacity, and functional outcomes: the cost of inexperience.
    Holshausen K; Bowie CR; Mausbach BT; Patterson TL; Harvey PD
    Schizophr Res; 2014 Feb; 152(2-3):430-4. PubMed ID: 23978775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.
    Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M
    J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum.
    Kontaxaki MI; Kattoulas E; Smyrnis N; Stefanis NC
    Psychiatriki; 2014; 25(1):27-38. PubMed ID: 24739500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder.
    Vaskinn A; Sundet K; Simonsen C; Hellvin T; Melle I; Andreassen OA
    Neuropsychology; 2011 Jul; 25(4):499-510. PubMed ID: 21463042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.